Atlas Turner Newalls Newtempheit

Product Description

Newtempheit was a high-temperature industrial material produced under the Atlas Turner Newalls product line and associated with ASARCO’s involvement in asbestos-containing construction and insulation products. The product belonged to a category of materials designed to withstand extreme thermal conditions in industrial settings, placing it among a class of specialty products used across cement pipe fabrication, pipe insulation systems, refractory applications, and spray-applied fireproofing installations.

Atlas Turner was a Canadian affiliate of Turner & Newall, one of the most extensively documented asbestos manufacturing enterprises in the twentieth century. Turner & Newall operated through a network of subsidiaries and affiliated brands across North America and internationally, producing a broad range of asbestos-containing products marketed under various trade names. Newtempheit appears in litigation records as one of those branded product lines, associated with refractory and thermal insulation applications where high asbestos content was considered a functional asset due to the mineral’s heat-resistant and binding properties.

ASARCO — the American Smelting and Refining Company — figures in asbestos litigation records as a manufacturer and distributor with documented connections to asbestos-containing product lines. ASARCO operated across mining, smelting, and industrial materials markets, and litigation records identify the company in connection with products containing asbestos that were distributed throughout industrial worksites in the United States and Canada.

The product’s name and category placement suggest it was engineered for environments where ordinary insulating or fireproofing materials would fail — industrial furnaces, high-temperature pipe systems, boiler installations, and structural fireproofing in facilities such as refineries, chemical plants, steel mills, and shipyards.

Asbestos Content

Litigation records identify Newtempheit as an asbestos-containing product. Specific fiber types and percentage compositions have not been independently confirmed through publicly available regulatory filings in connection with this particular product name; however, materials in the refractory, pipe insulation, cement pipe, and spray fireproofing categories manufactured during the periods associated with Atlas Turner Newalls product lines routinely incorporated chrysotile asbestos, and in many cases amosite or crocidolite asbestos, depending on application requirements.

Refractory and high-temperature insulation products of this era commonly used asbestos because no widely available substitute offered comparable resistance to heat, flame, and thermal cycling while also providing structural cohesion in bonded or sprayed applications. Plaintiffs in litigation involving Newtempheit alleged that the product contained asbestos in quantities sufficient to generate hazardous airborne fiber concentrations during normal handling, installation, and removal.

Spray-applied fireproofing products in particular have been extensively documented by OSHA and in asbestos abatement literature as high-exposure materials, because the application process itself — and subsequent disturbance during renovation or demolition — releases large quantities of respirable fibers into the breathing zone of workers and bystanders.

How Workers Were Exposed

Industrial workers generally represent the primary exposed population documented in connection with Newtempheit and comparable Atlas Turner Newalls product lines. Because the product spanned multiple categories — cement pipe, pipe insulation, refractory, and spray fireproofing — the range of trades and worksite conditions associated with potential exposure was correspondingly broad.

Workers involved in the fabrication or cutting of cement pipe products containing asbestos were exposed through the generation of dust during sawing, drilling, and fitting operations. Pipe insulation work — including the application of insulating materials to high-temperature pipe systems in industrial plants — created fiber-releasing dust during mixing, application, trimming, and finishing. Refractory work in furnaces, kilns, and boiler settings involved breaking apart, installing, and repairing high-heat materials that litigation records document as significant sources of asbestos fiber release.

Spray fireproofing applications created among the most acute exposure conditions documented in occupational asbestos literature. Workers applying spray-applied fireproofing materials worked in enclosed or semi-enclosed spaces with concentrations of airborne asbestos fiber that OSHA records and industrial hygiene studies have identified as far exceeding what would later become permissible exposure limits. Plaintiffs alleged that workers applying, trimming, or working in proximity to Newtempheit spray fireproofing materials inhaled substantial quantities of asbestos fibers over extended periods.

Secondary or bystander exposure was also documented in litigation records. Workers in adjacent trades — electricians, pipefitters, ironworkers, boilermakers, and general laborers working in the same industrial environments — were exposed to asbestos fibers released during Newtempheit application or disturbance without directly handling the product themselves. Litigation records document that this pattern of bystander exposure is consistent with the general industrial worksites where high-temperature insulation and fireproofing products of this type were used.

Latency periods for asbestos-related disease typically range from ten to fifty years following initial exposure, meaning that workers exposed to Newtempheit during the mid-twentieth century may be experiencing or may yet develop related diagnoses including mesothelioma, asbestosis, lung cancer, or other asbestos-related conditions.

Newtempheit, as a product associated with ASARCO and the Atlas Turner Newalls product line, falls within the category of litigated asbestos products. Individuals diagnosed with mesothelioma, lung cancer, asbestosis, or other asbestos-related diseases who worked with or around this product may have legal remedies available through civil litigation.

Litigation pathway: Litigation records document claims filed against ASARCO and related entities in connection with asbestos-containing products. Plaintiffs alleged that ASARCO and affiliated manufacturers knew or should have known of the hazards associated with asbestos-containing products and failed to adequately warn workers of those risks. Civil litigation in state and federal courts remains an active avenue for individuals and families harmed by exposure to this product line.

ASARCO Asbestos Personal Injury Settlement Trust: ASARCO filed for bankruptcy reorganization, and as part of that process, an asbestos personal injury settlement trust was established to compensate individuals with claims arising from ASARCO’s asbestos-related liabilities. Individuals with documented exposure to ASARCO-associated products and a qualifying diagnosis may be eligible to file a claim with this trust. Claim eligibility and compensation levels are governed by the trust’s trust distribution procedures (TDP), which define qualifying disease categories and exposure criteria.

Turner & Newall / Federal-Mogul Asbestos Personal Injury Trust: Given the Atlas Turner and Newalls connection to the Turner & Newall corporate family, claims related to this product may also implicate the Federal-Mogul Asbestos Personal Injury Trust, which was established following Federal-Mogul’s acquisition of Turner & Newall and subsequent bankruptcy proceedings. Claimants with documented exposure to Turner & Newall affiliated products should discuss eligibility for this trust with qualified asbestos litigation counsel.

Anyone diagnosed with an asbestos-related illness who has a documented work history involving Newtempheit or related Atlas Turner Newalls products should consult with an attorney experienced in asbestos personal injury claims. Statutes of limitations vary by jurisdiction and typically begin running from the date of diagnosis rather than the date of exposure, making timely legal consultation important.